Cellebrite DI Ltd.
11.43USD
-0.0200 (-0.17%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 270.7M | 325.1M | 401.2M | 475.7M | 556.7M | 640.9M |
| Q1 | — | — | — | 107.5M | 128.3M | — |
| Q2 | — | — | — | 113.3M | — | — |
| Q3 | — | — | — | 126.0M | 145.9M | — |
| Q4 | — | — | — | 128.8M | 151.4M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | .590 | -.430 | -1.35 | .310 | .549 | .653 |
| Q1 | — | — | — | .070 | .040 | — |
| Q2 | — | — | — | .080 | — | — |
| Q3 | — | — | — | .080 | .158 | — |
| Q4 | — | — |
Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| — |
| .080 |
| .176 |
| — |